Trial record 1 of 711 for:    Open Studies | "Personal Health Records"
Previous Study | Return to List | Next Study

Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified December 2013 by Cedars-Sinai Medical Center
Sponsor:
Information provided by (Responsible Party):
Josh Pevnick, Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier:
NCT02026453
First received: December 31, 2013
Last updated: NA
Last verified: December 2013
History: No changes posted
  Purpose

We will test two interventions to improve the accuracy of medication histories obtained at hospital admission. The interventions will target elderly and chronically ill patients prone to erroneous medication histories and resultant medication errors. For targeted patients, we will test the effect of using pharmacists and pharmacy technicians to obtain an initial medication history. This will be studied using a randomized controlled trial of usual care (which involves nurses and physicians) vs usual care + pharmacists vs usual care + pharmacy technicians to obtain an admission medication history.

Our overarching hypothesis is that by leveraging pharmacists and pharmacy technicians we can minimize admission medication history errors and related downstream events.


Condition Intervention Phase
Adverse Drug Events
Other: Pharmacist obtains admission medication history
Other: Pharmacy technician obtains admission medication history
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy

Further study details as provided by Cedars-Sinai Medical Center:

Primary Outcome Measures:
  • Medication History Errors, or Medication Order Errors [ Time Frame: within 48 hours of hospital admission ] [ Designated as safety issue: Yes ]
    The project was originally funded to measure the effect of these interventions on medication history errors. We are currently applying for more funding which would allow us to use the more meaningful, more downstream outcome of medication order errors, and this will become the primary outcome if funding for such is received.


Estimated Enrollment: 300
Study Start Date: January 2014
Estimated Study Completion Date: February 2014
Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Usual care
Experimental: Pharmacist obtains home med hx
Pharmacist obtains admission medication history
Other: Pharmacist obtains admission medication history
Experimental: Pharm tech obtains home med hx
Pharmacy technician obtains admission medication history
Other: Pharmacy technician obtains admission medication history

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. ≥ 10 chronic prescribed meds in electronic health record when patient considered for inclusion
  2. Acute myocardial infarction in problem list
  3. Congestive heart failure in problem list
  4. Admitted from skilled nursing facility
  5. On anticoagulants
  6. On insulin
  7. On narrow therapeutic index drugs:

    1. Carbamazepine
    2. Clindamycin
    3. Clonidine
    4. Cyclosporine
    5. Digoxin
    6. Lithium
    7. Phenytoin
    8. Prazosin
    9. Sirolimus
    10. Tacrolimus
    11. Valproic acid/valproate sodium syrup

9. History of transplant

  • Exclusion (where any exclusion criteria trumps any inclusion criteria):

    1. Admit to pediatric primary
    2. Transplant team listed as being on the Treatment Team
    3. Trauma patient
    4. Patient already randomized in this study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02026453

Sponsors and Collaborators
Cedars-Sinai Medical Center
Investigators
Principal Investigator: Joshua M Pevnick, MD, MSHS Cedars-Sinai Health System
  More Information

No publications provided

Responsible Party: Josh Pevnick, Assistant Professor, Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier: NCT02026453     History of Changes
Other Study ID Numbers: KL2TR000122-00032874
Study First Received: December 31, 2013
Last Updated: December 31, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Cedars-Sinai Medical Center:
Adverse drug events

Additional relevant MeSH terms:
Drug Toxicity
Poisoning
Substance-Related Disorders

ClinicalTrials.gov processed this record on July 24, 2014